Extended-Release Methylphenidate (Ritalin LA): A Viewpoint by Daniel J. Safer

By Safer D.J.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2260-2261

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Ritalin ® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

By Biederman J.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 833-841

Adis International

Access to resources Recommend Favorite

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite

Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite